Company profile for Ampio Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. We are developing compounds that serve significant medical needs in osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases through an innovative discovery and development plat...
Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. We are developing compounds that serve significant medical needs in osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases through an innovative discovery and development platform.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
373 Inverness Parkway, Suite 200 Englewood, CO 80112
Telephone
Telephone
+1 720 437 6500
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/01/29/3017459/0/en/Ampio-Announces-Notice-of-Proposed-Settlement-of-Stockholder-Derivative-Actions-and-Settlement-Hearing.html

GLOBENEWSWIRE
29 Jan 2025
Ampio prepares to wind down after final therapeutic dream dies
Ampio prepares to wind down after final therapeutic dream dies

26 Mar 2024

// James Waldron FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/ampio-prepares-wind-down-after-final-therapeutic-dream-dies

James Waldron FIERCE BIOTECH
26 Mar 2024

https://www.fiercebiotech.com/biotech/ampios-last-shot-success-fizzles-out-preclinical-stage-leaving-biotech-mull-options

FIERCE BIOTECH
15 Feb 2024

https://www.prnewswire.com/news-releases/ampio-provides-update-on-results-from-pre-ind-enabling-studies-302062348.html

PR NEWSWIRE
14 Feb 2024

https://www.prnewswire.com/news-releases/ampio-pharmaceuticals-to-present-at-the-emerging-growth-conference-301972378.html

PR NEWSWIRE
31 Oct 2023

https://www.prnewswire.com/news-releases/ampio-selects-ascendia-pharmaceuticals-inc-to-provide-cdmo-services-to-support-clinical-development-of-oa-201-301948936.html

PR NEWSWIRE
05 Oct 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty